The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Biotech.
Corporate venture armce.venturesRounds from 2020-02-03 to 2026-11-10
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Oyster Therapeutics A pharmaceutical company developing next-generation targeted protein degraders with an initial focus on tau-driven diseases like Alzheimer’s | Series A Verified against 4 of 21 sources | $60M | 2026-11-10 | [ PART ] |
Aptadir Therapeutics A preclinical biotech company developing a new class of RNA therapeutics | Seed |
| $44.7M |
| 2026-09-29 |
| [ PART ] |
Kitopi Restaurants, Food Delivery, Cloud Kitchens and more | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60M | 2020-02-03 | [ PART ] |